Find similar content

Source channel @githubtrending · Post #15029 · Aug 5

#java#cache#caffine#data#draft#fetch#graphql#immer#immutable#immutable_collections#immutable_datastructures#java#jdbc#kotlin#orm#orm_framework#orm_library#orms#redis#redis_cache Jimmer is a powerful and advanced ORM (Object-Relational Mapping) framework for Java and Kotlin that lets you easily read and write complex data structures without needing to predefine their shapes. It supports dynamic multi-table queries, automatic SQL optimization, and efficient saving of incomplete or nested objects. Jimmer also generates type-safe DTOs (Data Transfer Objects) for complex queries and updates, avoids common problems like "N+1" queries, and offers strong caching and GraphQL support. This means you can build complex business logic faster and with less hassle, improving both development speed and code quality. It works well with modern IDEs and supports both Java and Kotlin seamlessly. https://github.com/babyfish-ct/jimmer

Hashtags

#java #cache #caffine #data #draft #fetch #graphql #immer #immutable #immutable_collections #immutable_datastructures #jdbc #kotlin #orm #orm_framework #orm_library #orms #redis #redis_cache

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment